Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132024) titled 'Effects of Cornus officinalis Powder on Bone Health in Osteopenic Individuals' on Sept. 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First People's Hospital of Kunshan
Condition:
Osteopenia
Intervention:
Placebo group:microcrystalline cellulose
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-01
Target Sample Size: Placebo group:30;Investigational Product Group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=330598
Published by HT Digital Content Services with permission from H...